This observation strengthens the hypothesis that cancer-expressed SLFN11 is directly linked with neoplastic cell sensitivity to DDAs like platinum independently of immune infiltration, whereas the prognostic relevance of noncancer SLFN11 may underlie an “active” tumor immune milieu. Here, SLFN11 is linked to cancer.